Scientists are developing a microneedle patch that they hope could someday simplify IVF hormone delivery. They've tested it ...
The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.
The combination of subcutaneous daratumumab with VRd was approved in July 2024 for induction and consolidation in patients ...